Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Darrow

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Therapeutic Innovation & Regulatory Science|July 15, 2021
Government Pharmaceutical Development to Address High Prices: Challenges AheadJonathan J Darrow
Drug Discovery Today|February 4, 2019
Luxturna: FDA documents reveal the value of a costly gene therapyJonathan J Darrow
JAMA Health Forum|October 11, 2022
The Perils of Increasing Medicaid Rebates for Drugs With Accelerated ApprovalJonathan J Darrow
Cornell Journal of Law and Public Policy|December 15, 2017
Explaining the absence of surgical procedure regulationJonathan J Darrow
Health Marketing Quarterly|January 7, 2022
Two views of cancer medicines: Imagery versus evidenceJonathan J Darrow
Journal of Managed Care & Specialty Pharmacy|April 28, 2021
Few new drugs deserve expedited regulatory treatmentJonathan J Darrow
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 13, 2011
Recent developments in health law. Essential medicines: why international price discrimination may increasingly be the wrong solution to a global drug problemJonathan J Darrow
Nature|November 10, 2021
Simplify drug labelling to show benefits clearlyJonathan J Darrow
Health Matrix (Cleveland, Ohio : 1991)|December 18, 2013
An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in IndiaDipika Jain, Jonathan J Darrow
Journal of the American Board of Family Medicine : JABFM|July 27, 2022
Communication of Drug Efficacy Information via a Popular Online PlatformJonathan J Darrow, Elizaveta Borisova
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Therapeutic Innovation & Regulatory Science|July 15, 2021
Government Pharmaceutical Development to Address High Prices: Challenges AheadJonathan J Darrow
Drug Discovery Today|February 4, 2019
Luxturna: FDA documents reveal the value of a costly gene therapyJonathan J Darrow
JAMA Health Forum|October 11, 2022
The Perils of Increasing Medicaid Rebates for Drugs With Accelerated ApprovalJonathan J Darrow
Cornell Journal of Law and Public Policy|December 15, 2017
Explaining the absence of surgical procedure regulationJonathan J Darrow
Health Marketing Quarterly|January 7, 2022
Two views of cancer medicines: Imagery versus evidenceJonathan J Darrow
Journal of Managed Care & Specialty Pharmacy|April 28, 2021
Few new drugs deserve expedited regulatory treatmentJonathan J Darrow
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 13, 2011
Recent developments in health law. Essential medicines: why international price discrimination may increasingly be the wrong solution to a global drug problemJonathan J Darrow
Nature|November 10, 2021
Simplify drug labelling to show benefits clearlyJonathan J Darrow
Health Matrix (Cleveland, Ohio : 1991)|December 18, 2013
An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in IndiaDipika Jain, Jonathan J Darrow
Journal of the American Board of Family Medicine : JABFM|July 27, 2022
Communication of Drug Efficacy Information via a Popular Online PlatformJonathan J Darrow, Elizaveta Borisova
Pageof 9